The DOI matches its Crossref record.
The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations.
Abstract
The electrocardiographic effects of imipramine hydrochloride at therapeutic plasma concentrations were determined in 44 depressed patients during a 6-week clinical outcome study of depression. During each week of the protocol, i.e., 2 weeks of control and 4 weeks of drug treatment, a standard 12-lead ECG, high-speed, high-fidelity ECG tracings, and a 24-hour continuous ECG recording were obtained. PR, QRS, and QTc intervals, T-wave amplitude, heart rate and frequency of ventricular premature depolarizations (VPDs) were measured. The plasma concentration of imipramine and desmethylimipramine was measured three times a week. Imipramine prolonged the PR (p less than 0.001), QRS (p less than 0.001) and QTc (p less than 0.001) intervals, increased the heart rate (p less than 0.001) and lowered T-wave amplitude (p less than 0.05) during the 4 weeks of treatment. No patient developed high-grade atrioventricular block or severe intraventricular conduction abnormalities. In addition, imipramine had a potent antiarrhythmic action in patients who were recovering from depression. Ten of 11 patients who had more than 10 VPDs/hour had 90% or greater arrhythmia suppression during antidepressant treatment with imipramine at plasma concentrations ranging from 100--302 ng/ml.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02035-3 · Cited by 602
A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias
Mason, J. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308123290702 · Cited by 462
Depression in the medically ill: an overview
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.6.696 · Cited by 435
Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Pacher, P., & Kecskemeti, V. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383872 · Cited by 390
Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants in Children and Adolescents
WILENS, T. E., BIEDERMAN, J., BALDESSARINI, R. J., GELLER, B., SCHLEIFER, D., SPENCER, T. J., BIRMAHER, B., & GOLDBLATT, A. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199611000-00018 · Cited by 296
Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants: A Review
Glassman, A. H. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780320095011 · Cited by 269
Self-citationLong-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia
Mease, P. J., Russell, I. J., Kajdasz, D. K., Wiltse, C. G., Detke, M. J., Wohlreich, M. M., Walker, D. J., & Chappell, A. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.11.001 · Cited by 54
Metadata
- Authors
- Giardina, E. G., Bigger, J. T., Glassman, A. H., Perel, J. M., & Kantor, S. J.
- Venue
- Circulation
- Published
- 1979-11
- Volume
- 60
- Issue
- 5
- Pages
- 1045-1052
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1990443387
- Cited by
- 167
- References
- 0
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.